Key milestones for BioAlliance in the second quarter

Friday 5 March 2010

BioAlliance Pharma SA is looking ahead to three possibly transforming events in the second quarter of 2010 that could secure its standing as a recognised specialty pharmaceutical company in Europe.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

France